US approves cheap version of breakthrough HIV prevention shot: manufacturer
Health
Business
November 2, 2026
Share this article
Click to view full size
WASHINGTON, United States (AFP) — The United States (US) Food and Drug Administration on Monday approved a low-cost version of a twice-yearly HIV prevention shot, bringing the breakthrough drug closer to market in low-income countries.
The approval was announced by Dr Reddy’s Laboratories, the Indian maker of the generic version of lenacapavir, and by Unitaid, a global health initiative.
The generic will be available for $40 per person per year in 120 countries, under a pricing agreement announced in September 2025 between Dr Reddy’s and Unitaid, the African health research institute Wits RHI, and the Clinton Health Access Initiative (CHAI).
Health
Business
Need the bigger picture?
Share this article
Comments (0)
Download our mobile app
The portable companion to gazettE. Get notifications, track read articles, and more. The latest news from Trinidad and Tobago, in one place.
